$FNGR

FingerMotion Inc (FNGR) signed a non-binding MOU with Lyken AI Computing and BlueFlare Energy Solutions to collaborate on natural gas supply for energy projects in Alberta. FNGR's P/S ratio is 0.72, below its historical median of 6.88, indicating market skepticism. The company has a GF Score™ of 31/100, reflecting weak fundamentals. Insiders have net sold shares worth $28,020 over the past year. FNGR's market cap is $15M, and it remains unprofitable with negative cash flow.

FingerMotion (FNGR) filed an S-1 to register 25.5M shares for resale by a selling stockholder, issuable upon conversion of a $5M convertible note and exercise of a warrant. The company won't receive proceeds; it previously received $1.3M at closing. FNGR operates in China via a VIE structure and reports net losses. As of August 28, 2026, it had 75.2M shares outstanding, trading at $0.3980 per share.

U.S. stocks fell midday, with the Dow, Nasdaq, and S&P 500 down 0.64%, 0.40%, and 0.51% respectively. Energy shares rose 1.8%, while communication services dropped 1.9%. The Dallas Fed's manufacturing index surged to 11.6 in August. Notable movers: CLGN (+123%), ASND (+6%), TITN (+13%), FNGR (-39%), EIX (-23%), PCG (-20%). Oil gained 2.5% to $85.50, while gold fell 1.3% to $4,473.10. European and Asian markets were mixed.

FingerMotion, Inc. (FNGR) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. On August 31, 2026, FingerMotion, Inc. (the “ Company ”) entered into a securities purchase agreement (the “ Purchase Agreement ”) with an institutional investor (the “ Purchaser ”), which provides for the issuance and sale, i

U.S. stocks were mixed on Friday, with the Dow up 0.19% and the NASDAQ down 0.01%. The Chicago PMI fell to 47.1 in August, missing estimates. Quoin Pharmaceuticals (QNRX) rose 43% after positive clinical trial results and financing news. BioXcel Therapeutics (BTAI) dropped 73% after filing for bankruptcy.

FingerMotion (FNGR) plans to expand into North American AI compute infrastructure with modular, behind-the-meter facilities. The company acquired a 9.9% stake in Lyken.AI to access cloud-compute capacity. FingerMotion aims to reduce risk by deploying smaller facilities incrementally, focusing on power availability and customer demand. The strategy involves disciplined capital deployment and strengthening leadership. The company continues its existing mobile data and payment business in China, fo

CFO turnover at Fortune 500 and S&P 500 companies is projected to reach 18.3% in 2026, the highest since 2020. Key CFO changes include AT&T, Caterpillar, Oracle, Nike, and Pfizer. The average age of new CFOs is projected to be 48, down from 52 in 2025. Notable appointments include GE HealthCare, Baxter International, and Ameresco.

FingerMotion, Inc. (FNGR) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Exhibit 99.1 FingerMotion Completes Acquisition of 9.9% Interest in Lyken AI Computing Transaction Closes Following TSX Venture Exchange Approval; FingerMotion Formally Enters the Enterprise AI Compute Market WEST PALM BEACH, FL / ACCESS Newswire / August 17, 2026 / FingerMotion,

Alset AI Ventures Inc. (TSXV:GPUS, OTCQB:GPUSF) said it signed an agreement to sell FingerMotion, Inc. (Nasdaq:FNGR) a 9.9% stake in Lyken.AI by transferring 99,000 Lyken shares. FingerMotion will issue 1,674,480 FNGR shares worth $500,000, implying about $5M Lyken equity value. Closing is pending TSXV acceptance.

FingerMotion, Inc. (FNGR) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Exhibit 99.1 FingerMotion Announces Leadership Change Seasoned Nasdaq senior executive and corporate attorney brings proven public company leadership to FingerMotion Singapore, Singapore, August 5, 2026 (GLOBE NEWSWIRE) - FingerMotion, Inc. (NASDAQ: FNGR) (“ FingerMotion ” or the